Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial by Nadel, Simon, FRCP, Goldstein, Brahm, MD, Williams, Mark D, MD, Dalton, Heidi, MD, Peters, Mark, PhD, Macias, William L, MD, Abd-Allah, Shamel A, MD, Levy, Howard, FRCP, Angle, Robinette, RN, Wang, Dazhe, PhD, Sundin, David P, PhD, Giroir, Brett, Dr

Get full text

Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated database by Payen, Didier, MD, PhD, Sundin, David P., PhD, Nelson, David R., MS, Williams, Mark D., MD

Get full text